Institute for International Research

Brigitte Barbeau, Medicago

James Blackwell, Ph.D., M.B.A., BioProcess Technology Consultants, Inc.

Jeffrey T. Blue, Merck Research Laboratories

E.J. Brandreth, Ph.D., Althea Technologies

Michael V. Callahan, M.D., DTM&H, DARPA

Stewart A. Campbell, Ph.D., Ancora Pharmaceuticals, Inc.

Jean-François Chaubard, GlaxoSmithKline Biologicals, Belgium

Antu K. Dey, D.Phil., Novartis Vaccines & Diagnostics

Robert K. Evans, Ph.D., Merck Research Laboratories

Parrish M. Galliher, Xcellerex, Inc.

Philippe-Alexandre Gilbert, Ph.D., MedImmune Vaccines

Henry Hebel, VGXI, Inc.

Tony Hitchcock, RecipharmCobra Biologics, United Kingdom

Peter Latham, BioPharm Services US

Brian Lee, Ph.D., PBS Biotech, Inc.

Claudia Magagnoli, Ph.D., Novartis Vaccines & Diagnostics, Italy

Sunil Mehta, B.Pharm, Ph.D., KBI Biopharma Inc.

David R. Milich, Ph.D. , The Vaccine Research Institute of San Diego

Joseph A. Rininger, Ph.D., Protein Sciences Corporation

George A. Robertson, Ph.D., PATH

Paul Shabram, PaxVax

John Smit, Ph.D., University of British Columbia, Canada

Bryan L. Steadman, LigoCyte Pharmaceuticals, Inc.

Matthew Stober, Novartis Vaccines & Diagnostics

Aleš Štrancar, Ph.D., BIA Separations, Austria

Sara Terpening, Ph.D., DynPort Vaccine Company LLC

Mark W. Thompson, RPh, Ph.D., MedImmune Vaccines

Alex Tracy, Ph.D., Novartis Vaccines & Diagnostics

Vu L. Truong, Ph.D., Aridis Pharmaceuticals

Marloes Veenstra, Ph.D., Crucell, The Netherlands

Scott B. Winram, Ph.D., SAIC